The use of staurosporine analogues for enhancing neurotrophin activity

The staurosporine analogues BE-13793C, a monosaccharide derivative thereof, rebeccamycin and NB-506 are indicated for new therapeutic uses in conditions of neuronal degeneration such as Alzheimer's, Huntington's corea, epilepsy, and brain or spinal cord injuries. The compounds are believed...

Full description

Saved in:
Bibliographic Details
Main Authors HOWARD BARFF BROUGHTON, SCOTT JEFFREY POLLACK, SARAH JANE HARPER
Format Patent
LanguageEnglish
Published 01.12.1999
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The staurosporine analogues BE-13793C, a monosaccharide derivative thereof, rebeccamycin and NB-506 are indicated for new therapeutic uses in conditions of neuronal degeneration such as Alzheimer's, Huntington's corea, epilepsy, and brain or spinal cord injuries. The compounds are believed to potertrate neurotrophin-3 (NT-3) action without unhibiting tyrosine kinase (Trk).
AbstractList The staurosporine analogues BE-13793C, a monosaccharide derivative thereof, rebeccamycin and NB-506 are indicated for new therapeutic uses in conditions of neuronal degeneration such as Alzheimer's, Huntington's corea, epilepsy, and brain or spinal cord injuries. The compounds are believed to potertrate neurotrophin-3 (NT-3) action without unhibiting tyrosine kinase (Trk).
Author HOWARD BARFF BROUGHTON
SCOTT JEFFREY POLLACK
SARAH JANE HARPER
Author_xml – fullname: HOWARD BARFF BROUGHTON
– fullname: SCOTT JEFFREY POLLACK
– fullname: SARAH JANE HARPER
BookMark eNqFyjsKAjEQBuAUWvg6g3MBQTbF1iquHmD7ZQh_NoFlJuQheHst7K2-5tualahgY4YxgFoBqadSuWUtSXMUEAsvOjcU8poJElhclJkE31SzphCF2NX4ivW9N2vPS8Hh584ch_t4e56QdEJJ7CCo0-PaWdv35-5i_48Pxyw1Mw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 6
ExternalDocumentID GB2337702A
GroupedDBID EVB
ID FETCH-epo_espacenet_GB2337702A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:45:47 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_GB2337702A3
Notes Application Number: GB19990012318
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991201&DB=EPODOC&CC=GB&NR=2337702A
ParticipantIDs epo_espacenet_GB2337702A
PublicationCentury 1900
PublicationDate 19991201
PublicationDateYYYYMMDD 1999-12-01
PublicationDate_xml – month: 12
  year: 1999
  text: 19991201
  day: 01
PublicationDecade 1990
PublicationYear 1999
RelatedCompanies MERCK SHARP & DOHME LIMITED
RelatedCompanies_xml – name: MERCK SHARP & DOHME LIMITED
Score 2.5126398
Snippet The staurosporine analogues BE-13793C, a monosaccharide derivative thereof, rebeccamycin and NB-506 are indicated for new therapeutic uses in conditions of...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title The use of staurosporine analogues for enhancing neurotrophin activity
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991201&DB=EPODOC&locale=&CC=GB&NR=2337702A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV07T8MwED6VgoANCqi8PaBsEcVx22SIEEmaVkh9CBXUrYodh3ZxoiYVf5-zaYGlm2VLJz90_k7n-z4DPDgs7cgkkTZ3KbOZzJ5sTzjSTiiCpZukGTU53eGoM3hnr7P2rAaLLRfG6IR-GXFE9CiB_l6Z-7r4S2JFprayfORL7Mqf46kfWemGLuY9IaBZUeD3JuNoHFph6PcDa_TmU8fpdlv0ZQ_2dRCtVfZ7H4HmpBT_ASU-gYMJ2lLVKdSkasBRuP13rQGHw81zNzY3nleeQYznSdalJHlGMKDTIpSFrp2TJFE_-ZeSYPxJpFpoBQ31SYxSZbXKi8VSEU1f0L9EnMN93JuGAxsnNP9d-7wfbGfuXEBd5Uo2gWQic4UjhOfyFksRdNuaOSUYZ5R7XcovobnLytXuoWs4NpoEplbjBurVai1vEXErfmc26xuvDYfL
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH9BNOJNUYOf9GB2W4SusO2wGLcxUPmKQeONrF0nXLqFjfjv21ZQL9yaNnnpR15_7ev7_QpwZ5Gky-OYm9TBxCQ8bZsus7gZYwmWTpykWMd0R-Pu4I08f3Q-KrDYcmG0TuiXFkeUHsWkv5d6v87_glihzq0s7ulSVmUP0cwLjWRDF3PbEtCM0Pd600k4CYwg8Pq-MX71sGXZdgs_7sG-LS-ESmW_9-4rTkr-H1CiYziYSluiPIEKF3WoBdt_1-pwONo8d8vixvOKU4jkeqJ1wVGWInmgUyKUucqd4ygWP_GXAsnzJ-JioRQ0xCfSSpXlKssXS4EUfUH9EnEGzag3Cwam7ND8d-zzvr_tuXUOVZEJ3gCUstRhFmOuQ1skkaDbUcwpRijB1LUxvYDGLiuXu5uaUBvMRsP58Gn8cgVHWp9A521cQ7VcrfmNRN-S3uqJ-wYuVoq2
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=The+use+of+staurosporine+analogues+for+enhancing+neurotrophin+activity&rft.inventor=HOWARD+BARFF+BROUGHTON&rft.inventor=SCOTT+JEFFREY+POLLACK&rft.inventor=SARAH+JANE+HARPER&rft.date=1999-12-01&rft.externalDBID=A&rft.externalDocID=GB2337702A